ATE408610T1 - Alkyl-und piperidin-substitutierte benzimidazol- derivate - Google Patents

Alkyl-und piperidin-substitutierte benzimidazol- derivate

Info

Publication number
ATE408610T1
ATE408610T1 AT05778384T AT05778384T ATE408610T1 AT E408610 T1 ATE408610 T1 AT E408610T1 AT 05778384 T AT05778384 T AT 05778384T AT 05778384 T AT05778384 T AT 05778384T AT E408610 T1 ATE408610 T1 AT E408610T1
Authority
AT
Austria
Prior art keywords
alkyl
benzimidazole derivatives
substituted benzimidazole
piperidine substituted
pharmaceutically acceptable
Prior art date
Application number
AT05778384T
Other languages
German (de)
English (en)
Inventor
Ralf Anderskewitz
Domnic Martyres
Franz Birke
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE408610T1 publication Critical patent/ATE408610T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05778384T 2004-08-06 2005-07-30 Alkyl-und piperidin-substitutierte benzimidazol- derivate ATE408610T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04018690 2004-08-06

Publications (1)

Publication Number Publication Date
ATE408610T1 true ATE408610T1 (de) 2008-10-15

Family

ID=35463697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778384T ATE408610T1 (de) 2004-08-06 2005-07-30 Alkyl-und piperidin-substitutierte benzimidazol- derivate

Country Status (8)

Country Link
US (1) US7723360B2 (enExample)
EP (1) EP1776356B1 (enExample)
JP (1) JP4934030B2 (enExample)
AT (1) ATE408610T1 (enExample)
CA (1) CA2572740A1 (enExample)
DE (1) DE602005009839D1 (enExample)
ES (1) ES2314700T3 (enExample)
WO (1) WO2006013073A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US8273766B2 (en) 2007-04-04 2012-09-25 Kowa Company, Ltd. Tetrahydroisoquinoline compound
TWI433838B (zh) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 作為趨化因子受體活性調節劑之六氫吡啶衍生物
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
WO2002100861A1 (en) * 2001-06-13 2002-12-19 Akzo Nobel N.V. 1-(3-phenyloxypropyl)piperidine derivatives
JP4932135B2 (ja) * 2002-11-22 2012-05-16 武田薬品工業株式会社 イミダゾール誘導体、その製造法及び用途
EP1564213A4 (en) * 2002-11-22 2009-05-27 Takeda Pharmaceutical IMIDAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
JP2008509104A (ja) 2008-03-27
EP1776356A1 (en) 2007-04-25
ES2314700T3 (es) 2009-03-16
CA2572740A1 (en) 2006-02-09
EP1776356B1 (en) 2008-09-17
DE602005009839D1 (de) 2008-10-30
US7723360B2 (en) 2010-05-25
US20060030590A1 (en) 2006-02-09
WO2006013073A1 (en) 2006-02-09
JP4934030B2 (ja) 2012-05-16

Similar Documents

Publication Publication Date Title
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
CY1119261T1 (el) Παραγωγα θειαζολιου
EA201170176A1 (ru) Ингибитор stat3, содержащий хинолинкарбоксамидное производное в качестве активного ингредиента
MX2011012628A (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
BRPI0716598A2 (pt) Derivados de (hetero) arilsulfonamida de n-biarila úteis no tratamento de doenças medidas por interações de linfócitos
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA201070786A1 (ru) Бензофуропиримидиноны
DK2074120T3 (da) Tropan-forbindelser
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
SE0400284D0 (sv) Novel compounds
DE602005023015D1 (de) Indolderivate als viruzide
DE602005008953D1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
ATE440833T1 (de) Antithrombotische diamide
NO20085317L (no) Imidazoazepinonforbindelser
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
MX2008016358A (es) Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3.
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
DE602004026558D1 (de) Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren
ATE308540T1 (de) Antithrombosemittel
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE408610T1 (de) Alkyl-und piperidin-substitutierte benzimidazol- derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1776356

Country of ref document: EP